New Secondary Metabolites from the Marine-Derived Fungus Talaromyces mangshanicus BTBU20211089

Mar Drugs. 2022 Jan 18;20(2):79. doi: 10.3390/md20020079.

Abstract

Seven new compounds, namely talaromanloid A (1), talaromydene (2), 10-hydroxy-8-demethyltalaromydine and 11-hydroxy-8-demethyltalaromydine (3 and 4), talaromylectone (5), and ditalaromylectones A and B (6 and 7), together with seven known compounds were identified from a marine-derived fungus, Talaromyces mangshanicus BTBU20211089, which was isolated from a sediment sample collected from the South China Sea. Their chemical structures were determined using spectroscopic data, including HRESIMS, 1D, and 2D NMR techniques. The absolute configurations of 1 and 2 were elucidated by comparing experimental and calculated ECD spectra. Compounds 1, 2, 6, and 7 are new compounds possessing a novel carbon skeleton. Compound 6 is a dimeric molecule of 3 and 9. Compound 7 shared a unique structure of the cyclized dimer of 3 and 4. All the compounds were tested for their bioactivities against Staphylococcus aureus, Escherichia coli, and Candida albicans.

Keywords: Talaromyces mangshanicus; antibacterial; antifungal; marine-derived fungus.

MeSH terms

  • Anti-Infective Agents / isolation & purification
  • Anti-Infective Agents / pharmacology*
  • Candida albicans / drug effects
  • China
  • Escherichia coli / drug effects
  • Geologic Sediments / microbiology*
  • Oceans and Seas
  • Secondary Metabolism
  • Staphylococcus aureus / drug effects
  • Talaromyces / metabolism*

Substances

  • Anti-Infective Agents

Supplementary concepts

  • Talaromyces mangshanicus